Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: Activity ex vivo of cytotoxic drugs in patient samples of peritoneal carcinomatosis with special focus on colorectal cancer

Figure 1

IC 50 values for standard drugs in all peritoneal carcinoma samples investigated divided for the subtypes indicated. Results are presented as means valuesā€‰+ā€‰SE. Statistical inference was calculated with 1-way ANOVA with Dunnetā€™s post-test and with the colorectal cancer samples as reference. The following panel of 8 drugs were investigated: A ā€“ Oxaliplatin, B ā€“ Cisplatin, C ā€“ Melphalan, D ā€“ 5FU, E ā€“ Mitomycin C, F ā€“ Irinotecan, G ā€“ Docetaxel, H ā€“ Doxorubicin. *, ** and *** denotes Pā€‰<ā€‰0.05, 0.001 and 0.0001 vs. colorectal samples, respectively. Absence of asterixes means that no statistical differences compared to colorectal samples were observed.

Back to article page